Guizhou Yibai Pharmaceutical Co Ltd (600594) — Free Cash Flow Generation Index
Guizhou Yibai Pharmaceutical Co Ltd (600594) has a Free Cash Flow Generation Index of 0.79x as of September 2025. Free cash flow of CN¥26.20 Million represents 1% of operating cash flow (CN¥33.28 Million). Explore Guizhou Yibai Pharmaceutical Co Ltd (600594) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Guizhou Yibai Pharmaceutical Co Ltd Free Cash Flow Generation Index (2002–2025)
Historical FCF Generation Index trend for Guizhou Yibai Pharmaceutical Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see 600594 cash generation efficiency.
Annual Free Cash Flow Generation for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)
Year-by-year Free Cash Flow Generation Index for Guizhou Yibai Pharmaceutical Co Ltd. Check Guizhou Yibai Pharmaceutical Co Ltd (600594) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.86x | CN¥221.71 Million | CN¥256.71 Million | CN¥34.99 Million | ▲ +894.1% |
| 2024 | -0.11x | CN¥-9.45 Million | CN¥86.87 Million | CN¥96.32 Million | ▼ -116.6% |
| 2023 | 0.65x | CN¥247.23 Million | CN¥377.61 Million | CN¥130.38 Million | ▲ +910.4% |
| 2022 | 0.06x | CN¥22.38 Million | CN¥345.30 Million | CN¥322.92 Million | ▼ -87.6% |
| 2021 | 0.52x | CN¥486.43 Million | CN¥934.21 Million | CN¥447.78 Million | ▲ +756.5% |
| 2020 | -0.08x | CN¥-29.08 Million | CN¥366.66 Million | CN¥395.74 Million | ▼ -117.8% |
| 2019 | 0.45x | CN¥161.44 Million | CN¥362.71 Million | CN¥201.28 Million | ▲ +189.1% |
| 2018 | -0.50x | CN¥-107.03 Million | CN¥214.30 Million | CN¥321.33 Million | ▼ -222.1% |
| 2017 | 0.41x | CN¥278.98 Million | CN¥681.78 Million | CN¥402.80 Million | ▲ +223.9% |
| 2016 | 0.13x | CN¥48.08 Million | CN¥380.62 Million | CN¥332.53 Million | ▼ -74.6% |
| 2015 | 0.50x | CN¥285.66 Million | CN¥573.68 Million | CN¥288.02 Million | ▼ -20.1% |
| 2014 | 0.62x | CN¥337.65 Million | CN¥541.58 Million | CN¥203.94 Million | ▲ +18.5% |
| 2013 | 0.53x | CN¥303.76 Million | CN¥577.24 Million | CN¥273.48 Million | ▲ +93.4% |
| 2012 | 0.27x | CN¥78.37 Million | CN¥288.01 Million | CN¥209.64 Million | ▼ -44.2% |
| 2011 | 0.49x | CN¥135.49 Million | CN¥277.83 Million | CN¥142.34 Million | ▼ -14.5% |
| 2010 | 0.57x | CN¥66.01 Million | CN¥115.66 Million | CN¥49.66 Million | ▲ +0.0% |
| 2009 | 0.57x | CN¥59.26 Million | CN¥103.88 Million | CN¥44.62 Million | ▼ -14.6% |
| 2008 | 0.67x | CN¥126.40 Million | CN¥189.26 Million | CN¥62.86 Million | ▲ +129.5% |
| 2007 | -2.26x | CN¥-27.03 Million | CN¥11.94 Million | CN¥38.97 Million | ▼ -375.1% |
| 2006 | 0.82x | CN¥78.77 Million | CN¥95.77 Million | CN¥17.00 Million | ▲ +122.5% |
| 2005 | -3.66x | CN¥-63.60 Million | CN¥17.38 Million | CN¥80.99 Million | ▼ -335.6% |
| 2003 | -0.84x | CN¥-77.37 Million | CN¥92.10 Million | CN¥169.47 Million | ▼ -221.1% |
| 2002 | 0.69x | CN¥50.97 Million | CN¥73.46 Million | CN¥22.49 Million | — |